Hildred-backed Crown Laboratories acquires five OTC consumer brands from GSK

Crown Laboratories, a portfolio company of Hildred Capital Partners LLC, has acquired five over the counter consumer brands from GlaxoSmithKline. The acquired brands include PanOxyl, Sarna and Zeasorb. No financial terms were disclosed. Crosstree Capital Partners New York LLC and Latham & Watkins (London) LLP served as financial and legal advisers, respectively, to GlaxoSmithKline.

DealsNorth AmericaUSHealthcareBriefs